Struggling With Great Stock Picks? Discover StockInvest.us Top Gems!
Currently predicting for Thu, 16 May 2024

Trading levels for SRPT

Fibonacci Support & Resistance Levels

Level Price
Resistance R3 135.71 2.42 %
R2 134.72 1.67 %
R1 134.10 1.21 %
Current price: 132.50
Support S1 132.12 -0.287 %
S2 131.51 -0.749 %
S3 130.52 -1.50 %

Accumulated Volume Support & Resistance Levels

Level Price
Resistance R3 136.04 2.67 %
R2 134.61 1.59 %
R1 132.58 0.0604 %
Current price 132.50
Support S1 130.63 -1.41%
S2 128.67 -2.89%
S3 127.90 -3.47%

SRPT Predictions History

3 years ago
2poJeff predicted that SRPT for 2020-06-12 is going $160.70 (4.62%)

4 years ago
JS predicted that SRPT for 2020-02-28 is going $106.39 (-6.98%)

4 years ago
Samuel Sussman predicted that SRPT for 2020-02-28 is going

Rank:

4 years ago
2poJeff predicted that SRPT for 2020-02-28 is going $112.76 (4.73%)

4 years ago
JS predicted that SRPT for 2019-07-24 is going $147.38 (-1.35%)

4 years ago
Alan predicted that SRPT for 2019-07-24 is going $147.52 (-1.26%)

4 years ago
Chaser predicted that SRPT for 2019-06-20 is going $136.23 (4.64%)

5 years ago
joe1234 predicted that SRPT for 2019-05-14 is going $110.02 (-5.03%)

5 years ago
PumpTheseNumbers predicted that SRPT for 2019-05-02 is going $114.28 (-1.69%)

5 years ago
NameNotImportant predicted that SRPT for 2019-05-01 is going $113.80 (-1.56%)

Click to get the best stock tips daily for free!

About Sarepta Therapeutics

Sarepta Therapeutics Sarepta Therapeutics, Inc., a commercial-stage biopharmaceutical company, focuses on the discovery and development of RNA-targeted therapeutics, gene therapies, and other genetic therapeutic modalities for the treatment of rare diseases. It offers EXONDYS 51 injection to treat duchenne muscular dystrophy (duchenne) in patients with confirmed mutation of the dystrophin gene that is amenable to exon 51 skipping; and VYONDYS 53 for the treatment of ... SRPT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT